Journal
MOLECULAR IMAGING AND BIOLOGY
Volume 9, Issue 3, Pages 126-134Publisher
SPRINGER
DOI: 10.1007/s11307-007-0079-2
Keywords
adenovirus; firefly luciferase; reporter gene; integrin alpha(v)beta(3); RGD; bioluminescence imaging
Funding
- NCI NIH HHS [R21 CA102123, U54 CA119367, P50 CA114747, R24 CA93862] Funding Source: Medline
- NIBIB NIH HHS [R21 EB001785] Funding Source: Medline
Ask authors/readers for more resources
Purpose: The goal of this study is to demonstrate the feasibility of chemically modified human adenovirus (Ad) vectors for tumor retargeting. Procedures: E1- and E3-deleted Ad vectors carrying firefly luciferase reporter gene under cytomegalovirus promoter (AdLuc) was surface-modified with cyclic arginine-glycine-aspartic acid (RGD) peptides through a bifunctional poly(ethyleneglycol) linker (RGD-PEG-AdLuc) for integrin alpha(v)beta(3) specific delivery. The Coxsackie and adenovirus viral receptor (CAR) and integrin alpha(v)beta(3) expression in various tumor cell lines was determined by reverse transcriptase PCR and fluorescence-activated cell sorting. Bioluminescence imaging was performed in vitro and in vivo to evaluate RGD-modified AdLuc infectivity. Results: RGD-PEG-AdLuc abrogated the native CAR tropism and exhibited significantly enhanced transduction efficiency of integrin-positive tumors than AdLuc through intravenous administration. Conclusion: This approach provides a robust platform for site-specific gene delivery and noninvasive monitoring of the transgene delivery efficacy and homing.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available